AbbVie Common Stock (NYSE: ABBV) is having an overwhelmingly strong day in the market today, and for good reason. The company reported earnings ahead of expectations. Of course, this led to excitement among investors, pushing the stock upward and prompting our partners at Trade Ideas to send the alert. Currently (9:55), ABBV is trading at $66.83 per share after a gain of $1.79 per share or 2.75% thus far today.
ABBV Reports Strong Earnings
As mentioned above, AbbVie is having a great day in the market today after announcing its earnings for the first quarter. During the quarter, earnings came in at $1.28 per share, surpassing analyst estimates at $1.26 per share.
In terms of revenue, ABBV definitely did not disappoint. During the quarter, analysts expected that the company would generate revenue in the amount of $6.48 billion. However, the company actually reported revenue in the amount of $6.54 billion; once again, beating expectations.
Stop wasting your time! Find winning trades in minutes with Trade Ideas!
What We’ll Be Watching For Ahead
Moving forward, the CNA Finance team will be keeping a close eye on ABBV. In particular, we’re interested in following continued efforts with regard to Humira. After all, the product accounts for more than a half of ABBV overall revenue. Nonetheless, we’ll continue to follow the company closely and bring the news to you as it breaks!
Never Miss The News Again
Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!